References
Nicoli P, Familiari U, Bosa M, Allice T, Mete F, Morotti A, et al. HHV8-positive HIV-negative multicentric Castleman’s disease: early and sustained complete remission with rituximab therapy without reactivation of Kaposi sarcoma. Int J Hematol. 2009;90:392–6.
Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, Babinet P, et al. Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman’s disease. Blood. 1995;86:1276–80.
Antman K, Chang Y. Kaposi’s sarcoma. N Engl J Med. 2000;342:1027–38.
Dham A, Peterson BA. Castleman disease. Curr Opin Hematol. 2007;14:354–9.
Naresh KN, Rice AJ, Bower M. Lymph nodes involved by multicentric Castleman disease among HIV-positive individuals are often involved by Kaposi sarcoma. Am J Surg Pathol. 2008;32(7):1006–12.
Bower M, Powles T, Williams S, Davis TN, Atkins M, Montoto S, et al. Brief communication: rituximab in HIV-associated multicentric Castleman disease. Ann Intern Med. 2007;147(12):836–9.
Oksenhendler E. HIV-associated multicentric Castleman disease. Curr Opin HIV AIDS. 2009;4(1):16–21.
Pastor MA, Vasco B, Mosquera JM, Debén G, Bautista P, Requena. Two HHV8-related illnesses in a HIV-negative patient: Kaposi’s sarcoma and multicentric Castleman’s disease. Response to treatment with Rituximab and CHOP. Acta Dermosifiliogr. 2006;97(6):385–90.
Marcelin AG, Aaron L, Mateus C, Gyan E, Gorin I, Viard JP, et al. Rituximab therapy for HIV-associated Castleman disease. Blood. 2003;102(8):2786–8.
Clifford KS, Demierre MF. Progression of classic Kaposi’s sarcoma with rituximab. J Am Acad Dermatol. 2005;53:155–7.
Bollen J, Polstra A, Van Der Kuyl A, Weel J, Noorduyn L, Van Oers M, et al. Multicentric Castleman’s disease and Kaposi’s sarcoma in a cyclosporin treated, HIV-1 negative patient: case report. BMC Blood Disord. 2003;3(1):3.
Stebbing J, Gazzard B, Newsom-Davis T, Nelson M, Patterson S, Gotch F, et al. Nadir B cell counts are significantly correlated with the risk of Kaposi’s sarcoma. Int J Cancer. 2004;108:473–4.
Author information
Authors and Affiliations
Corresponding author
Additional information
An answer to this letter to the editor is available at doi:10.1007/s12185-010-0498-8.
About this article
Cite this article
Law, A.B., Ryan, G., Lade, S. et al. Development of Kaposi’s sarcoma after complete remission of multicentric Castlemans disease with rituximab therapy in a HHV8-positive, HIV-negative patient. Int J Hematol 91, 347–348 (2010). https://doi.org/10.1007/s12185-010-0497-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12185-010-0497-9